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CLINICAL INQUIRIES
What is the best treatment 
for nocturnal enuresis in children?
■ Evidence summary
Nocturnal enuresis is an involuntary loss of
urine at night in the absence of congenital or
acquired central nervous system defect
among children over 5 years of age.1–4
Approximately 15% of children aged >5
years wet their bed at night.5 The sponta-
neous resolution rate is about 15% per year.5
Before primary care treatment, indications
for urological referral should be excluded,
including daytime wetting, abnormal void-
ing (unusual posturing, discomfort, strain-
ing, or poor urine stream), recurrent urinary
tract infections, neurological and anatomical
anomalies, and urgency symptoms.4
The Cochrane Incontinence Group
Trials demonstrated that enuresis alarms led
to nearly 4 fewer wet nights per week 
compared with no treatment or placebo
(weighted mean difference [WMD] = –3.65;
95% confidence interval [CI], –4.52 to
–2.78).1 The relative risk of failure was 0.36
compared with placebo (95% CI, 0.26 to
0.40). The number needed to treat (NNT)
to achieve 14 consecutive dry nights is 2.
About half the children relapse after stop-
ping treatment, compared with nearly all
children after control interventions (55% vs
99%). Evidence is insufficient to say
whether the addition of dry bed training
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C L I N I C A L C O M M E N T A R Y
Alarms have a high success rate with commitment;
desmopressin good for temporary reduction
Nocturnal enuresis is embarrassing to children and
frustrating to parents. Even though it has a usually
benign, self-limited course, many families want to
hear about treatment options. Enuresis alarms
have a high success rate in achieving dry nights
during treatment and maintaining dry nights once
treatment stops. The success of alarms requires a
motivated child and family plus a significant time
and effort commitment for 3 to 6 months. 
Since desmopressin rapidly reduces bedwetting,
it is a good choice for situational use such as
sleepovers, camping, and holidays. Desmopressin
has minimal adverse reactions such as nasal 
irritation, nausea, and headaches, but parents
should minimize evening water intake to prevent
rare water intoxication side effects. The lack of
benefit of desmopressin and alarm combination
therapy may be partly explained by the loss of
learning, if desmopressin negates the alarm 
needing to trigger. Since tricyclic medications 
do not show a benefit over desmopressin, they
should be considered second-line agents due 
to cardiotoxic side effects and life-threatening 
overdose outcomes.
For children with primary nocturnal enuresis, 
treatment with enuresis alarms reduced the 
number of wet nights by almost 4 per week, with
almost half of patients remaining dry for 3 months
after treatment (strength of recommendation
[SOR]: A, based on a systematic review of 
homogeneous randomized control trials [RCTs]).
Desmopressin (DDAVP) and tricyclic drugs reduce
the number of wet nights by 1 to 2 per week 
during treatment, although the effect is not 
sustained after treatment is finished (SOR: A,
based on a SR of homogeneous RCTs). Dry bed
training with an alarm results in an additional
reduction of wet nights over alarms alone 
(SOR: A, based on a systematic review of 
homogeneous RCTs].
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Alarms reduce the
number of wet
nights by almost 4
per week; adding
dry bed training
helps even more
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FAST TRACK
T A B L E
TREATMENT EFFICACY
Enuresis alarms • Reduction in 4 wet nights per week
• NNT=2 in achieving 14 consecutive dry nights
• 50% stay dry after treatment ends
Desmopressin • Reduction in 1 to 2 wet nights per week
• NNT=7 in achieving 14 consecutive dry nights
• High relapse rate
Tricyclic drugs • Reduction in 1 wet night per week
• NNT=6 in achieving 14 consecutive dry nights
• High relapse rate
Dry bed training • Mild additional benefit over alarms alone
with an alarm • 38% relapse rate 
Nocturnal enuresis treatments and efficacy
(scheduled awakenings, cleanliness training,
social reinforcement, positive practice)
improves the outcomes. Alarms that wake
the child immediately (vs a time delay) and
alarms that wake the child (instead of the
parents) were slightly more effective. 
A meta-analysis also showed that
desmopressin (10-60 µg) at bedtime
reduced bedwetting by 1 to 2 nights per
week compared with placebo (WMD=1.34;
95% CI, –1.57 to –1.11 with a dose of 20
µg).6 The NNT to achieve 14 consecutive
dry nights is 7. However, the data suggest
once treatment stops, there is little differ-
ence between desmopressin and placebo.
Some evidence suggested that a higher dose
was more likely to decrease the number of
wet nights; however, there was no difference
in cure rates. Evidence comparing intranasal
with oral administration is insufficient .2
In the Cochrane review, children treat-
ed with desmopressin had 1.7 fewer wet
nights (WMD=1.7; 95% CI, –2.95 to
–0.45) in the first week compared with
children treated with alarms.6 However, at
the end of 3 months, alarms were associat-
ed with 1.4 fewer wet nights per week than
children treated with desmopressin
(WMD=1.4; 95% CI, 0.14 to 2.66). 
Evidence is conflicting for increased
efficacy for combining desmopressin with
enuresis alarms. There is some limited
evidence that children receiving combina-
tion treatment with desmopressin and
alarms had fewer wet nights than children
treated with alarms and placebo.6 This
combination treatment did not show a
benefit with failure rates (not attaining 14
consecutive dry nights) or a statistically
significant difference in failure and
relapse rates once treatment stopped. In
addition, one RCT in which desmo-
pressin nonresponders were supplement-
ed with alarms showed no added benefit
in remission rates compared with condi-
tioning alarms plus placebo (51% vs 48%
in achieving 28 dry nights).7 Neither was
there added benefit in relapse rates once
treatment stopped. 
Children treated with tricyclic drugs
compared with those treated with placebo
had approximately 1 less night of enuresis
per week (WMD=1.19; 95% CI, –1.56 to
-0.82).8  More children achieved 14 dry
nights while on imipramine compared
with placebo (21% vs 5%; NNT=6); how-
ever, this advantage was not sustained once
treatment finished (96% vs 97% relapsed).
Little evidence exists to compare desmo-
pressin with tricyclic drugs.2,8
Simple behavior methods may be
more effective than no treatment, but
there is little evidence for how these meth-
ods compare with one another, or with
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more successful means of treatment.9
Behavior techniques include lifting (taking
a sleeping child to urinate in the bath-
room), waking, rewards, and evening
fluid restriction. 
Dry bed training refers to comprehen-
sive regimes, including enuresis alarms,
waking routines, positive practice, cleanli-
ness training, and bladder training in vari-
ous combinations. A meta-analysis exam-
ining dry bed training including an enure-
sis alarm showed children had fewer wet
nights compared with children receiving
no treatment (relative risk [RR] of fail-
ure=0.17; 95% CI, 0.11–0.28).2,10
Additionally, more children remained dry
after treatment stopped (RR of
relapse=0.25; 95% CI, 0.16–0.39).
However, evidence was not sufficient to
show a remission benefit for dry bed train-
ing without an alarm (RR of failure=0.82;
95% CI, 0.6–1.02), highlighting the key
role for alarm therapy. On the other hand,
dry bed training including bed alarms may
reduce the relapse rate compared with
alarm monotherapy (RR for failure or
relapse=0.5; 95% CI, 0.31–0.8)
Recommendations from others
A recent evidence-based practice parameter
from the American Academy of Child and
Adolescent Psychiatry states once the histo-
ry and physical suggest primary nocturnal
enuresis, treatment should include educa-
tion demystification and withholding pun-
ishment.4 Although insufficient evidence
exists to recommend behavioral interven-
tions such as journal keeping, fluid restric-
tions, and night awakenings, these support-
ive approaches are acceptable, benign start-
ing points. Conditioning with an enuresis
alarm and overlearning, which involves
giving extra fluids at bedtime after success-
fully becoming dry and intermittent rein-
forcement before ending treatment, is a
highly effective first-line management
approach. Medication choices include
desmopressin and imipramine, although
relapse rates are high. Short-term use of
desmopressin may be used for sleepovers or
camping trips. ■
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Desmopressin and
tricyclics reduce
wet nights by 
1 or 2 per week, 
but the effect
stops after 
treatment ends
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